UA88601C2 - Промотор il-18bp, его получение и применение - Google Patents

Промотор il-18bp, его получение и применение

Info

Publication number: UA88601C2
Authority: UA; Ukraine
Prior art keywords: dna sequence; promoter; virus; vector; cell
Prior art date: 2002-10-10

Application number

UAA200504334A

Other languages

English (en)

Ukrainian (uk)

Inventor

Даниэла Новик

Менахем Рубинштейн

Владимир Хургин

Original Assignee

Йеда Рисерч Энд Дивелопмент Ко. Лтд.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-10

Filing date

2003-10-09

Publication date

2009-11-10

2003-10-09 Application filed by Йеда Рисерч Энд Дивелопмент Ко. Лтд. filed Critical Йеда Рисерч Энд Дивелопмент Ко. Лтд.

2009-11-10 Publication of UA88601C2 publication Critical patent/UA88601C2/ru

Links

210000004027 cell Anatomy 0.000 abstract 6
108091028043 Nucleic acid sequence Proteins 0.000 abstract 5
241000700605 Viruses Species 0.000 abstract 4
102000044166 interleukin-18 binding protein Human genes 0.000 abstract 4
108010070145 interleukin-18 binding protein Proteins 0.000 abstract 4
108090000623 proteins and genes Proteins 0.000 abstract 3
108020004414 DNA Proteins 0.000 abstract 2
239000012634 fragment Substances 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
230000001105 regulatory effect Effects 0.000 abstract 2
102100025621 Cytochrome b-245 heavy chain Human genes 0.000 abstract 1
241000702421 Dependoparvovirus Species 0.000 abstract 1
208000031886 HIV Infections Diseases 0.000 abstract 1
208000037357 HIV infectious disease Diseases 0.000 abstract 1
241000699660 Mus musculus Species 0.000 abstract 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
208000016532 chronic granulomatous disease Diseases 0.000 abstract 1
238000012258 culturing Methods 0.000 abstract 1
210000003958 hematopoietic stem cell Anatomy 0.000 abstract 1
208000018706 hematopoietic system disease Diseases 0.000 abstract 1
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
210000004962 mammalian cell Anatomy 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
210000001616 monocyte Anatomy 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000002463 transducing effect Effects 0.000 abstract 1
238000011830 transgenic mouse model Methods 0.000 abstract 1
241001430294 unidentified retrovirus Species 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Pharmacology & Pharmacy (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Cell Biology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Biotechnology (AREA)
Virology (AREA)
General Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Diabetes (AREA)
Microbiology (AREA)
Oncology (AREA)
Physics & Mathematics (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Plant Pathology (AREA)
Hematology (AREA)
AIDS & HIV (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

UAA200504334A 2002-10-10 2003-10-09 Промотор il-18bp, его получение и применение UA88601C2 (ru)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IL15223202A IL152232A0 (en)	2002-10-10	2002-10-10	Promoter to il-18bp, its preparation and use

Publications (1)

Publication Number	Publication Date
UA88601C2 true UA88601C2 (ru)	2009-11-10

Family

ID=29765055

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UAA200504334A UA88601C2 (ru)	2002-10-10	2003-10-09	Промотор il-18bp, его получение и применение

Country Status (21)

Country	Link
US (1)	US7868154B2 (ru)
EP (1)	EP1556412B1 (ru)
JP (1)	JP4579688B2 (ru)
KR (1)	KR101140498B1 (ru)
CN (1)	CN100372871C (ru)
AT (1)	ATE454401T1 (ru)
AU (1)	AU2003269465B2 (ru)
BR (1)	BR0315222A (ru)
CA (1)	CA2501879C (ru)
CY (1)	CY1109904T1 (ru)
DE (1)	DE60330886D1 (ru)
DK (1)	DK1556412T3 (ru)
EA (1)	EA007460B1 (ru)
ES (1)	ES2335489T3 (ru)
IL (2)	IL152232A0 (ru)
MX (1)	MXPA05003871A (ru)
NO (1)	NO334018B1 (ru)
PT (1)	PT1556412E (ru)
SI (1)	SI1556412T1 (ru)
UA (1)	UA88601C2 (ru)
WO (1)	WO2004033694A2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009045370A2 (en)	2007-09-28	2009-04-09	Intrexon Corporation	Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
WO2011084455A2 (en) *	2009-12-16	2011-07-14	Opko Curna, Llc.	Treatment of membrane bound transcription factor peptidase, site 1 (mbtps1) related diseases by inhibition of natural antisense transcript to mbtps1
PT3282835T (pt) *	2015-04-13	2023-07-25	Univ Yale	Ratinhos knockin de sirpa-il15 humanizadas e métodos de utilização dos mesmos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4966843A (en) *	1982-11-01	1990-10-30	Cetus Corporation	Expression of interferon genes in Chinese hamster ovary cells
JP2524939B2 (ja) *	1991-12-03	1996-08-14	株式会社ニチレイ	エンハンサ−及びその用途
IL121860A0 (en) *	1997-08-14	1998-02-22	Yeda Res & Dev	Interleukin-18 binding proteins their preparation and use

2002
- 2002-10-10 IL IL15223202A patent/IL152232A0/xx unknown
2003
- 2003-10-09 BR BR0315222-7A patent/BR0315222A/pt not_active Application Discontinuation
- 2003-10-09 US US10/530,963 patent/US7868154B2/en not_active Expired - Lifetime
- 2003-10-09 ES ES03751245T patent/ES2335489T3/es not_active Expired - Lifetime
- 2003-10-09 DK DK03751245.6T patent/DK1556412T3/da active
- 2003-10-09 WO PCT/IL2003/000815 patent/WO2004033694A2/en not_active Ceased
- 2003-10-09 JP JP2004542765A patent/JP4579688B2/ja not_active Expired - Lifetime
- 2003-10-09 PT PT03751245T patent/PT1556412E/pt unknown
- 2003-10-09 AT AT03751245T patent/ATE454401T1/de active
- 2003-10-09 SI SI200331744T patent/SI1556412T1/sl unknown
- 2003-10-09 EA EA200500624A patent/EA007460B1/ru not_active IP Right Cessation
- 2003-10-09 KR KR1020057005962A patent/KR101140498B1/ko not_active Expired - Lifetime
- 2003-10-09 CN CNB2003801048864A patent/CN100372871C/zh not_active Expired - Lifetime
- 2003-10-09 AU AU2003269465A patent/AU2003269465B2/en not_active Expired
- 2003-10-09 DE DE60330886T patent/DE60330886D1/de not_active Expired - Lifetime
- 2003-10-09 EP EP03751245A patent/EP1556412B1/en not_active Expired - Lifetime
- 2003-10-09 UA UAA200504334A patent/UA88601C2/ru unknown
- 2003-10-09 MX MXPA05003871A patent/MXPA05003871A/es active IP Right Grant
- 2003-10-09 CA CA2501879A patent/CA2501879C/en not_active Expired - Lifetime
2005
- 2005-03-31 IL IL167768A patent/IL167768A/en active IP Right Grant
- 2005-04-20 NO NO20051938A patent/NO334018B1/no not_active IP Right Cessation
2010
- 2010-03-29 CY CY20101100288T patent/CY1109904T1/el unknown

Also Published As

Publication number	Publication date
CA2501879C (en)	2017-08-29
JP2006501839A (ja)	2006-01-19
SI1556412T1 (sl)	2010-03-31
EA007460B1 (ru)	2006-10-27
NO334018B1 (no)	2013-11-18
EP1556412A2 (en)	2005-07-27
CA2501879A1 (en)	2004-04-22
KR101140498B1 (ko)	2012-04-30
CY1109904T1 (el)	2014-09-10
BR0315222A (pt)	2005-08-23
PT1556412E (pt)	2010-02-02
NO20051938L (no)	2005-04-20
US7868154B2 (en)	2011-01-11
AU2003269465A1 (en)	2004-05-04
IL152232A0 (en)	2003-05-29
DK1556412T3 (da)	2010-04-26
WO2004033694A3 (en)	2004-05-27
ATE454401T1 (de)	2010-01-15
AU2003269465B2 (en)	2007-07-12
EA200500624A1 (ru)	2005-10-27
KR20050083727A (ko)	2005-08-26
EP1556412B1 (en)	2010-01-06
IL167768A (en)	2012-09-24
HK1082510A1 (zh)	2006-06-09
WO2004033694A2 (en)	2004-04-22
MXPA05003871A (es)	2005-06-22
US20060239984A1 (en)	2006-10-26
CN100372871C (zh)	2008-03-05
JP4579688B2 (ja)	2010-11-10
ES2335489T3 (es)	2010-03-29
DE60330886D1 (de)	2010-02-25
CN1726225A (zh)	2006-01-25

Publication	Publication Date	Title
CN112266411B (zh)	2022-06-24	一种新型冠状病毒疫苗及其应用
CN102227501B (zh)	2016-11-16	基因治疗载体和胞嘧啶脱氨酶
Bamford et al.	1996	Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region/IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation.
DK1317537T3 (da)	2007-04-30	Sammensætninger og fremgangsmåder med G-CSF analoger
CN102741405A (zh)	2012-10-17	提高基因表达的系统和保持有该系统的载体
US20240200042A1 (en)	2024-06-20	Limited self-replicating mrna molecular system, producing method and use
KR20140107616A (ko)	2014-09-04	사람 아르기나제 및 페길화된 사람 아르기나제 및 그의 적용
US20110008283A1 (en)	2011-01-13	Interferon fusion proteins
BR9814546A (pt)	2000-10-10	"liberação de dna de plasmìdeo codificando polipeptìdeos no citossol de macrófagos por bactérias suicidas atenuadas"
US8956623B2 (en)	2015-02-17	Recombinant fusion interferon for animals
CN112424361A (zh)	2021-02-26	核酸构建体
EP4584287A1 (en)	2025-07-16	Il-18 variant polypeptides
JP2007508019A5 (ru)	2007-12-06
CN101921330B (zh)	2013-07-17	重组人干扰素α1b突变体及其制备方法
CN103665166A (zh)	2014-03-26	犬融合干扰素
Kim et al.	2023	Interferon alpha and beta receptor 1 knockout in human embryonic kidney 293 cells enhances the production efficiency of proteins or adenoviral vectors related to type I interferons
US20240197921A1 (en)	2024-06-20	Signal peptides
US9029522B2 (en)	2015-05-12	Recombinant fusion interferon for animals
FI117054B (fi)	2006-05-31	Interleukiini-15:n valmistusmenetelmä ja sitä koodaava DNA-sekvenssi
Shayesteh et al.	2020	Design, construction, and expression of recombinant human interferon beta gene in CHO-s cell line using EBV-based expression system
CN109609553B (zh)	2022-06-24	提高nk细胞靶向作用力的方法及ccr5基因的应用
JPWO2010082622A1 (ja)	2012-07-05	ヒトβ−ヘキソサミニダーゼＢの基質特異性を変換した新規高機能酵素
EP2177606A3 (fr)	2010-07-21	N-désoxyribosyltransferases de lactobacilles, séquences nucléotidiques correspondantes et leurs applications
CN116024263A (zh)	2023-04-28	一种高效表达猪HIF-1α基因的真核表达载体及其构建方法
An et al.	2023	Biological Activity of Optimized Codon Bovine Type III Interferon Expressed in Pichia pastoris